UBE2I and cancer: To further validate the UBE2I expression in PTC, Western blotting (WB) validation using clinical samples revealed that UBE2I expression was significantly higher in cancer tissues than in paracancerous tissues (Fig. 1C), and the results were consistent with the data from TCGA database.